Impact Journals Spotlight
ONCOTARGET
VIEW MORE ONCOTARGET ARTICLES ➜
ONCOSCIENCE
Behind the Study: Targeting Glioblastoma with Nitrosylcobalamin
Dr. Joseph A. Bauer discusses a research paper he co-authored, titled “Selective blood–brain barrier penetration and tumor targeting of nitrosylcobalamin in glioblastoma: Pharmacokinetics, tissue distribution, and synergistic activity with TRAIL and temozolomide.”
Behind the Study: Advance Cancer Therapy Using Functional Information
Dr. R. Craig Herndon from the Department of Radiation Oncology at the Shannon Medical Center in San Angelo, TX, shares a presentation on a recent editorial he authored that was published by Oncoscience in Volume 11, entitled, “Functional information offers…
Behind the Study: Global Pandemic Exit Strategy: Equity and Immunity
Dr. Lennard YW Lee, Yuxin Ying and Jola Bytyci from the University of Oxford, UK, elaborate on a recent editorial they co-authored that was published by Oncoscience in Volume 10, entitled, “Exiting the pandemic together: achieving global immunity and equity.”
VIEW MORE ONCOSCIENCE ARTICLES ➜
GENES & CANCER
Behind the Study: EBV (EBNA1) Upregulates Derlin1 & PSMD10 in HeLa Cells
Amir Hossein Alipour, from the Department of Microbiology and Immunology at the University of Tehran, explains the research paper he co-authored in Volume 16 of Genes & Cancer, titled “Epstein-Barr virus nuclear antigen 1 upregulates Derlin1 and PSMD10 expression in…
Behind the Study: Reaching Beyond Family History as Inclusion Criteria for Pancreatic Cancer Surveillance in High-risk Populations
Dr. Louise Wang from Yale School of Medicine and the VA Connecticut Healthcare system, describes a recent editorial she co-authored that was published by Genes & Cancer, entitled, “Reaching beyond family history as inclusion criteria for pancreatic cancer surveillance in…
VIEW MORE GENES & CANCER ARTICLES ➜
VIEW MORE SPOTLIGHT ARTICLES ➜











